International molecular screening program for metastatic breast cancer AURORA at IMPAKT
AURORA is a large international molecular screening programme for metastatic breast cancer aiming to improve understanding of the disease and its response to treatments. The study will analyze over 1300 patients' tissue and plasma samples, enabling scientists to identify genetic characteristics that predict treatment outcomes.